Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential Therapy (NRX-100 Followed by NRX-101) for the Treatment of Acute Suicidal Ideation and Behavior in Bipolar Depression: the STABIL-B Study

NCT02974010 is registered in ClinicalTrials.gov with NeuroRx, Inc. as lead sponsor.

NCT NCT02974010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential Therapy (NRX-100 Followed by NRX-101) for the Treatment of Acute Suicidal Ideation and Behavior in Bipolar Depression: the STABIL-B Study
Lead sponsor
NeuroRx, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2018
Completion date
November 20, 2019
Enrollment
22 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, suicidal ideas, suicidal ideation, suicide, attempted